Latest Medicinal Cannabis News

Page 8 of 8
Cann Group Limited reported a positive operating cash flow for Q2 2024, driven by an R&D tax credit refund, while ramping up production and navigating pricing pressures in the medicinal cannabis market.
Ada Torres
Ada Torres
31 Jan 2025
Little Green Pharma reports a robust 75% revenue increase to $9.5 million for December quarter, driven by strong European market growth and strategic product launches.
Ada Torres
Ada Torres
31 Jan 2025
IDT Australia reports a near doubling of quarterly revenue to $5.3 million, driven by explosive growth in its Advanced Therapies segment, with first-half revenue expected to jump 82%.
Victor Sage
Victor Sage
28 Jan 2025
ECS Botanics reports a striking 339% quarter-on-quarter growth in its B2C sales, offsetting a slight dip in total revenue as it pivots to a hybrid B2B and B2C business model. The company’s record harvest and new product launches position it for a promising turnaround.
Ada Torres
Ada Torres
28 Jan 2025